Title:
SMALL-MOLECULE DRUG SUSTAINED-RELEASE DELIVERY SYSTEM
Document Type and Number:
WIPO Patent Application WO/2023/025272
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition, comprising a pharmaceutically active ingredient, glycerol, a sustained-release carrier, and a pharmaceutically acceptable solvent. The pharmaceutical composition is small in irritation, has good sustained-release performance, medication safety and tolerance, is high-viscosity liquid at normal temperature, and is particularly beneficial to perfusion administration.
Inventors:
LI LING (CN)
WU QU (CN)
CHU XIAN (CN)
WANG JIAO (CN)
WANG QINGSONG (CN)
WU QU (CN)
CHU XIAN (CN)
WANG JIAO (CN)
WANG QINGSONG (CN)
Application Number:
PCT/CN2022/115027
Publication Date:
March 02, 2023
Filing Date:
August 26, 2022
Export Citation:
Assignee:
NANJING DELOVA BIOTECH CO LTD (CN)
International Classes:
A61K47/10; A61K9/00; A61K9/08; A61K45/00; A61K47/24
Foreign References:
| CN113941002A | 2022-01-18 | |||
| CN113018248A | 2021-06-25 | |||
| CN102688482A | 2012-09-26 |
Other References:
"Pharmaceutics", 30 November 2013, LIAONING UNIVERSITY PRESS, Shenyang, CN, ISBN: 7-5610-7514-6, article ZHANG CHAOYUN, QIN YADONG: "Glycerol", pages: 209 - 210, XP009544039
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF:
Previous Patent: CRYSTAL FORM OF PYRAZINE DERIVATIVE AND PREPARATION METHOD THEREFOR
Next Patent: VEGF BINDING MOLECULE AND USE THEREOF
Next Patent: VEGF BINDING MOLECULE AND USE THEREOF